Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor
Conditions
Acute Myeloid Leukemia (AML) · Chronic Myeloid Leukemia · Myelodysplastic Syndromes (MDS) · Myeloprolipherative Neoplsm · Atypical Chronic Myeloid Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Pavlov University, Saint Petersburg, Russia